A Positive Impact on 3 Key Measures of Multiple Sclerosis (MS) Disease Activity Versus Placebo at Week 108 with AUBAGIO 14 mg1,2

Stuart SchlossmanOral MS Medications

Hear from Our Expert

Listen to an engaging and informative audio presentation by Dr. Steven Cavalier, Senior Medical Director for AUBAGIO at Genzyme, about the effects of AUBAGIO on MRI disease activity and what it may mean for your patients with MS.

AUBAGIO EFFECT ON MRI DISEASE ACTIVITY – Dr. Steven Cavalier

00:41/03:31

  To listen to this audio presentation, Please click here

Once-daily AUBAGIO® (teriflunomide) 14 mg tablets. AUBAGIO® is available in 14 mg and 7 mg tablets.

~~~~~~~~~~~~~~~~~~~~
 Keep CURRENT and up to date, with MS News and Information
Sign-up for emails 

.

WATCH OUR MS EDUCATIONAL VIDEOS by Topic, 

.

Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews